Michael Sarcone
Stock Analyst at Jefferies
(n/a)
# 4,745
Out of 5,044 analysts
8
Total ratings
n/a
Success rate
-36.38%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Michael Sarcone
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INSP Inspire Medical Systems | Downgrades: Hold | $160 → $85 | $77.17 | +10.15% | 1 | Oct 24, 2025 | |
| ALGN Align Technology | Downgrades: Hold | $215 → $140 | $133.14 | +5.15% | 1 | Oct 10, 2025 | |
| EDAP EDAP TMS | Downgrades: Hold | $8 → $2 | $1.81 | +10.50% | 2 | Apr 4, 2025 | |
| PRCT PROCEPT BioRobotics | Initiates: Hold | $95 | $36.95 | +157.10% | 1 | Nov 14, 2024 | |
| GKOS Glaukos | Upgrades: Buy | $84 → $125 | $77.79 | +60.69% | 1 | May 6, 2024 | |
| PROF Profound Medical | Downgrades: Equal-Weight | $5.5 → $10 | $6.20 | +61.29% | 1 | Mar 21, 2023 | |
| AXGN Axogen | Assumes: Buy | $15 | $18.08 | -17.04% | 1 | Nov 11, 2022 |
Inspire Medical Systems
Oct 24, 2025
Downgrades: Hold
Price Target: $160 → $85
Current: $77.17
Upside: +10.15%
Align Technology
Oct 10, 2025
Downgrades: Hold
Price Target: $215 → $140
Current: $133.14
Upside: +5.15%
EDAP TMS
Apr 4, 2025
Downgrades: Hold
Price Target: $8 → $2
Current: $1.81
Upside: +10.50%
PROCEPT BioRobotics
Nov 14, 2024
Initiates: Hold
Price Target: $95
Current: $36.95
Upside: +157.10%
Glaukos
May 6, 2024
Upgrades: Buy
Price Target: $84 → $125
Current: $77.79
Upside: +60.69%
Profound Medical
Mar 21, 2023
Downgrades: Equal-Weight
Price Target: $5.5 → $10
Current: $6.20
Upside: +61.29%
Axogen
Nov 11, 2022
Assumes: Buy
Price Target: $15
Current: $18.08
Upside: -17.04%